These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7717894)

  • 1. Hepatitis C: a current perspective.
    Farrell GC
    Aust Fam Physician; 1995 Mar; 24(3):321-5; 328-9. PubMed ID: 7717894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding hepatitis C.
    Yim CK
    CANNT J; 2001; 11(3):24-30, 33-40; quiz 31-2, 41-2. PubMed ID: 11785189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis C].
    Krarup HB; Krogsgaard K
    Ugeskr Laeger; 1994 Jul; 156(28):4129-34. PubMed ID: 8066908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis C: epidemiology and therapy--with special reference to long-term prognosis after IFN therapy].
    Fujiyama S; Tanaka M
    Rinsho Byori; 2000 Jan; 48(1):5-13. PubMed ID: 10756668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Viral hepatitis C].
    Janković S
    Med Pregl; 1999; 52(11-12):459-63. PubMed ID: 10748768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of hepatitis C.
    Lok AS; Gunaratnam NT
    Hepatology; 1997 Sep; 26(3 Suppl 1):48S-56S. PubMed ID: 9305664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factors related to screening of hepatitis C virus in general medicine].
    Rotily M; Loubière S; Prudhomme J; Portal I; Tran A; Hofliger P; Valla D; Moatti JP
    Gastroenterol Clin Biol; 2002 Mar; 26(3):261-9. PubMed ID: 11981471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.
    Rodger AJ; Roberts S; Lanigan A; Bowden S; Brown T; Crofts N
    Hepatology; 2000 Sep; 32(3):582-7. PubMed ID: 10960453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection: an overview.
    Hwang SJ
    J Microbiol Immunol Infect; 2001 Dec; 34(4):227-34. PubMed ID: 11825001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient to patient transmission of hepatitis C virus in hemodialysis units.
    Taskapan H; Oymak O; Dogukan A; Utas C
    Clin Nephrol; 2001 Jun; 55(6):477-81. PubMed ID: 11434360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C: How should we manage the patient?
    Main J; Thomas H
    J Viral Hepat; 2004 Sep; 11 Suppl 1():19-22. PubMed ID: 15357859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis C epidemiology at a general hospital center. Management and natural history as a function of the manner of identification].
    Cadranel JF; Di Martino V; Cesbron H; Cazier A; Demontis R; Coutarel P; Bachmeyer C; Cordier F; Lukumbo S; Fiévet P; Mougeot-Martin M; Van Batten C; Devergie B; Dumouchel P
    Gastroenterol Clin Biol; 2000 Feb; 24(2):161-7. PubMed ID: 12687956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of anti-HCV IgM antibodies in patients with chronic hepatitis C treated with interferon.
    Picciotto A; Icardi G; Bardellini E; Borro P; Borzone S; Pireddu M; Sinelli N; Pezzano D; Orione L; Di Giacomo C
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):623-5. PubMed ID: 8590156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cold activation of complement for monitoring the response to interferon in patients with chronic hepatitis C.
    Akahane Y; Miyazaki Y; Naitoh S; Takeda K; Tsuda F; Okamoto H; Itoh K; Miyakawa Y; Mayumi M
    Am J Gastroenterol; 1996 Feb; 91(2):319-27. PubMed ID: 8607500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office.
    ; Yee HS; Currie SL; Darling JM; Wright TL
    Am J Gastroenterol; 2006 Oct; 101(10):2360-78. PubMed ID: 17032203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
    Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.